Chan Chee-Kai, Brignole Edward J, Gibson Wade
Virology Laboratories, Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
J Virol. 2002 Sep;76(17):8667-74. doi: 10.1128/jvi.76.17.8667-8674.2002.
The human cytomegalovirus (HCMV) maturational proteinase is synthesized as an enzymatically active 74-kDa precursor that cleaves itself at four sites. Two of these, called the maturational (M) and release (R) sites, are conserved in the homologs of all herpesviruses. The other two, called the internal (I) and cryptic (C) sites, have recognized consensus sequences only among cytomegalovirus (CMV) homologs and are located in the 28-kDa proteolytic portion of the precursor, called assemblin. I-site cleavage cuts assemblin in half without detected effect on its enzymatic behavior in vitro. To investigate the requirement for this cleavage during virus infection, we used the CMV-bacterial artificial chromosome system (E. M. Borst, G. Hahn, U. H. Koszinowski, and M. Messerle, J. Virol. 73:8320-8329, 1999) to construct a virus encoding a mutant I site (Ala143 to Val) intended to be blocked for cleavage. Characterizations of the resulting mutant (i) confirmed the presence of the mutation in the viral genome and the inability of the mutant virus to effect I-site cleavage in infected cells; (ii) determined that the mutation has no gross effect on the rate of virus production or on the amounts of extracellular virions, noninfectious enveloped particles (NIEPs), and dense bodies; (iii) established that assemblin and its cleavage products are present in NIEPs but are absent from CMV virions, an apparent difference from what is found for virions of herpes simplex virus; and (iv) showed that the 23-kDa protein product of C-site cleavage is more abundant in mutant virus-than in wild-type virus-infected cells and NIEPs. We conclude that the production of infectious CMV requires neither I-site cleavage of assemblin nor the presence of assemblin in the mature virion.
人巨细胞病毒(HCMV)成熟蛋白酶以一种具有酶活性的74 kDa前体形式合成,该前体在四个位点进行自我切割。其中两个位点,称为成熟(M)位点和释放(R)位点,在所有疱疹病毒的同源物中是保守的。另外两个位点,称为内部(I)位点和隐蔽(C)位点,仅在巨细胞病毒(CMV)同源物中具有公认的共有序列,且位于前体的28 kDa蛋白水解部分,称为装配素。I位点切割将装配素切成两半,但在体外未检测到对其酶活性的影响。为了研究病毒感染过程中这种切割的必要性,我们使用CMV细菌人工染色体系统(E.M. Borst、G. Hahn、U.H. Koszinowski和M. Messerle,《病毒学杂志》73:8320 - 8329,1999年)构建了一种编码突变I位点(Ala143突变为Val)的病毒,旨在阻止其切割。对所得突变体的表征如下:(i)证实病毒基因组中存在该突变,且突变病毒在感染细胞中无法进行I位点切割;(ii)确定该突变对病毒产生速率或细胞外病毒粒子、非感染性包膜颗粒(NIEP)和致密体的数量没有显著影响;(iii)确定装配素及其切割产物存在于NIEP中,但在CMV病毒粒子中不存在,这与单纯疱疹病毒病毒粒子的情况明显不同;(iv)表明C位点切割产生的23 kDa蛋白产物在突变病毒感染的细胞和NIEP中比在野生型病毒感染的细胞中更丰富。我们得出结论,感染性CMV的产生既不需要装配素的I位点切割,也不需要成熟病毒粒子中存在装配素。